Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019

<b>Background:</b> Two changes to gestational diabetes mellitus (GDM) testing were implemented in the Australian Capital Territory in 2015 and 2017. <b>Aims:</b> We aimed to determine the associations between testing regimes and the prevalence of GDM and large-for-gestational...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Hutchinson, Catherine R. Knight-Agarwal, Christopher J. Nolan, Deborah Davis
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Diabetology
Subjects:
Online Access:https://www.mdpi.com/2673-4540/6/6/54
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433883172405248
author Jennifer Hutchinson
Catherine R. Knight-Agarwal
Christopher J. Nolan
Deborah Davis
author_facet Jennifer Hutchinson
Catherine R. Knight-Agarwal
Christopher J. Nolan
Deborah Davis
author_sort Jennifer Hutchinson
collection DOAJ
description <b>Background:</b> Two changes to gestational diabetes mellitus (GDM) testing were implemented in the Australian Capital Territory in 2015 and 2017. <b>Aims:</b> We aimed to determine the associations between testing regimes and the prevalence of GDM and large-for-gestational-age (LGA) and small-for-gestational-age (SGA) infants and to compare the prevalence of LGA and SGA infants between women with and without GDM in each testing period. <b>Methods:</b> A total of 23,790 singleton live births with estimated GDM testing and birth dates between June 2012 and December 2019 were stratified into groups: pre-testing changes (June 2012–December 2014, group 1, <i>n</i> = 8069), revised diagnostic criteria (January 2015–May 2017, group 2, <i>n</i> = 8035) and changed pathology centrifugation protocol (June 2017-December 2019, group 3, <i>n</i> = 7686). Women were allocated to groups based on their estimated GDM testing date and stratified by their GDM status. A chi-square test, pairwise z-tests and logistic regression tested the associations. <b>Results:</b> The GDM prevalence significantly increased from 9.5% (group 1) to 19.4% (group 2) to 26.3% (group 3) (all: <i>p</i> < 0.001). The LGA infant prevalence significantly decreased in non-GDM women following revised diagnostic criteria implementation (11.6% vs. 9.7%, <i>p</i> = 0.001). Compared to group 1, women with GDM in groups 2 and 3 had significantly reduced odds of having LGA infants (aOR = 0.73, 95% CI of 0.56–0.95 and <i>p</i> = 0.021 and aOR = 0.75, 95% CI of 0.59–0.97 and <i>p</i> = 0.029, respectively). Compared to group 1, non-GDM women in groups 2 and 3 had significantly reduced odds of having LGA infants (aOR = 0.83, 95% CI of 0.74–0.92 and <i>p</i> < 0.001 and aOR = 0.88, 95% CI of 0.79–0.99 and <i>p</i> = 0.026, respectively). There were no significant associations for group 3 compared to group 2 nor for SGA infants. <b>Conclusions:</b> While significantly increasing the GDM prevalence, implementing the testing changes was associated with a reduced whole-population LGA infant prevalence without a change in the SGA infant prevalence.
format Article
id doaj-art-02da010c25264fd28aa6cd77aa6fa5da
institution Kabale University
issn 2673-4540
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Diabetology
spelling doaj-art-02da010c25264fd28aa6cd77aa6fa5da2025-08-20T03:26:52ZengMDPI AGDiabetology2673-45402025-06-01665410.3390/diabetology6060054Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019Jennifer Hutchinson0Catherine R. Knight-Agarwal1Christopher J. Nolan2Deborah Davis3Faculty of Health, University of Canberra, Canberra 2617, AustraliaFaculty of Health, University of Canberra, Canberra 2617, AustraliaSchool of Medicine and Psychology, College of Science and Medicine, Australian National University, Canberra 2601, AustraliaFaculty of Health, University of Canberra, Canberra 2617, Australia<b>Background:</b> Two changes to gestational diabetes mellitus (GDM) testing were implemented in the Australian Capital Territory in 2015 and 2017. <b>Aims:</b> We aimed to determine the associations between testing regimes and the prevalence of GDM and large-for-gestational-age (LGA) and small-for-gestational-age (SGA) infants and to compare the prevalence of LGA and SGA infants between women with and without GDM in each testing period. <b>Methods:</b> A total of 23,790 singleton live births with estimated GDM testing and birth dates between June 2012 and December 2019 were stratified into groups: pre-testing changes (June 2012–December 2014, group 1, <i>n</i> = 8069), revised diagnostic criteria (January 2015–May 2017, group 2, <i>n</i> = 8035) and changed pathology centrifugation protocol (June 2017-December 2019, group 3, <i>n</i> = 7686). Women were allocated to groups based on their estimated GDM testing date and stratified by their GDM status. A chi-square test, pairwise z-tests and logistic regression tested the associations. <b>Results:</b> The GDM prevalence significantly increased from 9.5% (group 1) to 19.4% (group 2) to 26.3% (group 3) (all: <i>p</i> < 0.001). The LGA infant prevalence significantly decreased in non-GDM women following revised diagnostic criteria implementation (11.6% vs. 9.7%, <i>p</i> = 0.001). Compared to group 1, women with GDM in groups 2 and 3 had significantly reduced odds of having LGA infants (aOR = 0.73, 95% CI of 0.56–0.95 and <i>p</i> = 0.021 and aOR = 0.75, 95% CI of 0.59–0.97 and <i>p</i> = 0.029, respectively). Compared to group 1, non-GDM women in groups 2 and 3 had significantly reduced odds of having LGA infants (aOR = 0.83, 95% CI of 0.74–0.92 and <i>p</i> < 0.001 and aOR = 0.88, 95% CI of 0.79–0.99 and <i>p</i> = 0.026, respectively). There were no significant associations for group 3 compared to group 2 nor for SGA infants. <b>Conclusions:</b> While significantly increasing the GDM prevalence, implementing the testing changes was associated with a reduced whole-population LGA infant prevalence without a change in the SGA infant prevalence.https://www.mdpi.com/2673-4540/6/6/54gestational diabetes mellitusdiagnostic criteriaglycolysisOGTTglucosepregnancy
spellingShingle Jennifer Hutchinson
Catherine R. Knight-Agarwal
Christopher J. Nolan
Deborah Davis
Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
Diabetology
gestational diabetes mellitus
diagnostic criteria
glycolysis
OGTT
glucose
pregnancy
title Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
title_full Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
title_fullStr Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
title_full_unstemmed Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
title_short Changes to Gestational Diabetes Mellitus (GDM) Testing and Associations with the GDM Prevalence and Large- and Small-for-Gestational-Age Infants—An Observational Study in an Australian Jurisdiction, 2012–2019
title_sort changes to gestational diabetes mellitus gdm testing and associations with the gdm prevalence and large and small for gestational age infants an observational study in an australian jurisdiction 2012 2019
topic gestational diabetes mellitus
diagnostic criteria
glycolysis
OGTT
glucose
pregnancy
url https://www.mdpi.com/2673-4540/6/6/54
work_keys_str_mv AT jenniferhutchinson changestogestationaldiabetesmellitusgdmtestingandassociationswiththegdmprevalenceandlargeandsmallforgestationalageinfantsanobservationalstudyinanaustralianjurisdiction20122019
AT catherinerknightagarwal changestogestationaldiabetesmellitusgdmtestingandassociationswiththegdmprevalenceandlargeandsmallforgestationalageinfantsanobservationalstudyinanaustralianjurisdiction20122019
AT christopherjnolan changestogestationaldiabetesmellitusgdmtestingandassociationswiththegdmprevalenceandlargeandsmallforgestationalageinfantsanobservationalstudyinanaustralianjurisdiction20122019
AT deborahdavis changestogestationaldiabetesmellitusgdmtestingandassociationswiththegdmprevalenceandlargeandsmallforgestationalageinfantsanobservationalstudyinanaustralianjurisdiction20122019